$ACT

Enact to Host Third Quarter 2026 Earnings Call November 5th

Enact Holdings (Nasdaq: ACT) will release its Q3 2026 earnings on November 4, followed by a conference call on November 5 at 8:00 a.m. ET. The company provides mortgage insurance and is headquartered in Raleigh, North Carolina. Investors can access the earnings materials and webcast via the company's investor relations website.

Original reporting
Published Oct 8, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 9:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Enact to Host Third Quarter 2026 Earnings Call November 5th — source image
Decision brief

The 30-second read

$ACTNeutralLow
01

Why it matters

The announcement sets the timeline for investors to prepare for the earnings release but does not contain any financial metrics or guidance.

02

Market read

Provides a date for the upcoming earnings release; limited immediate trading relevance.

03

What to watch

Potential market reaction may depend on upcoming earnings guidance and any surprise in the results.

Relevance 4/10Novelty 3/10Timing: Nov 5, 2026 (post‑market release)

Background

Enact Holdings (NASDAQ: ACT) is a U.S. private mortgage‑insurance provider. The press release schedules its Q3 2026 earnings release for November 4, 2026, with a conference call on November 5.

Company-level read

Ticker impact

$ACTNeutralHigh confidence
Context

Enact Holdings announced the date and time of its Q3 2026 earnings release and conference call.

Expected impact

likely neutral as the market awaits the actual earnings numbers.

Evidence & confidence

No new guidance or results were disclosed; only the timing of the upcoming release was provided.

Market effects

None disclosed; the announcement does not affect the broader mortgage‑insurance sector.

Limited to U.S. investors tracking Enact Holdings.

Minimal, as the news is company‑specific without macro implications.

Counterpoint

Traders could consider short positions if they anticipate weaker-than‑expected earnings, but the announcement alone offers no basis.

Key entities

  • Enact Holdings, Inc.

    U.S. mortgage‑insurance provider.

Related articles

$ACTMed

JPMorgan downgrades Enact Holdings stock rating on valuation

JPMorgan downgraded Enact Holdings (ACT) to Underweight, lowering its price target to $44.00. The stock trades at $45.97, above the target and fair value estimates, suggesting overvaluation. JPMorgan cited premium valuation and mixed effects from higher interest rates. Enact reported Q2 2026 earnings beating estimates, with $1.26 EPS and $317.3M revenue. BTIG initiated coverage with a Neutral rating, noting expected ROE declines.

$ACTMedAI 8/10

Enact (ACT) Q2 2026 Earnings Call Transcript

Enact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.

$LSTRMed

StoneX reiterates Hold on Landstar stock after insurance costs hit

StoneX kept a Hold rating on Landstar System (LSTR) after Q3 2026 earnings missed estimates due to higher insurance costs. EPS was $1.42, below StoneX's $1.61 estimate and consensus of $1.67. Revenue rose to $1.507B, slightly above forecasts. Analysts lowered price targets, citing cost concerns. LSTR trades at a P/E of 36.88 and is considered undervalued by InvestingPro.